missing translation for 'onlineSavingsMsg'
Learn More

STEMCELL Technologies KU0060648

Product Code. 17110322
Encompass_Preferred
Change view
Click to view available options
Quantity:
10 mg
Unit Size:
10mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity unitSize
17110322 10 mg 10mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Product Code. 17110322 Supplier STEMCELL Technologies Supplier No. 74062

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

NHEJ pathway inhibitor; Inhibits DNA-dependent protein kinase (DNA-PK)

  • KU0060648 is an ATP-competitive and highly potent inhibitor of DNA-dependent protein kinase (DNA-PK), with IC50 values of 19 nM in MCF7 human breast cancer cells and 170 nM in SW620 human colon cancer cells
  • KU0060648 also inhibits phosphoinositide 3-kinase (PI3K) with IC50 values of 39 nM in MCF7 cells and > 10 μM in SW620 cells, which suggests a cell-dependent mechanism (Munck et al.)
  • Reduces the frequency of non-homologous end joining (NHEJ) and increases the efficiency of homology-directed repair (HDR) in CRISPR-Cas9 genome editing (Robert et al.)
  • Inhibits tumor growth and sensitizes human cancer cells to DNA double-strand-break (DSB)-inducing therapies (chemo- or radio-therapy) by inhibiting both DNA-PK and PI3K and preventing the execution of DSB repair (Chen et al.; Dietlein et al.; Munck et al.)

Specifications

CAS 881375-00-4
Quantity 10 mg
Molecular Formula C33H34N4O4S
Purity ≥98%
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.